MDMA for treatment of PTSD and neurorehabilitation in military populations
Neurorehabilitation September 27, 2024 Walter Dunn, Anya K. Bershad, David E. Krantz et al. 2 citations
MDMA-assisted therapy for PTSD, supported by late-stage clinical trials, may be especially beneficial for military populations. MDMA's pro-social and fear-regulating properties could enhance the therapeutic alliance and patient engagement during neurorehabilitation. The molecular mechanism of MDMA is outlined, and a novel application for neurorehabilitation is proposed. Similarities in patient-therapist dynamics between PTSD treatment and neurorehabilitation suggest that MDMA's ability to downregulate fear, increase cognitive flexibility, and improve alliance could aid military personnel both with and without PTSD.